dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies

Autor: Luis Prieto, Ignacio Dávila, Christian Domingo, Oscar Palomares, Antonio Nieto, Marta Lleonart, Silvia Sánchez-Ramón, Luis Pérez de Llano

Publikováno v: E-Prints Complutense. Archivo Institucional de la UCM
instname
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
International Journal of Molecular Sciences
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
E-Prints Complutense: Archivo Institucional de la UCM
Universidad Complutense de Madrid
GREDOS. Repositorio Institucional de la Universidad de Salamanca

[EN] Asthma is an airway disease characterised by chronic inflammation with intermittent or permanent symptoms including wheezing, shortness of breath, chest tightness, and cough, which vary in terms of their occurrence, frequency, and intensity. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d50550c2d9a9468a16b35c25683ff5c
https://eprints.ucm.es/id/eprint/66287/1/ijms-18-01328.pdf

Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting

Autor: Antoni Sicras, Maribel Cuesta, J. Galera, Raquel Lahoz, Max Brosa, Carles Crespo, Marc Miravitlles, Marta Lleonart, Maria Isabel Riera

Publikováno v: Therapeutic Advances in Respiratory Disease, Vol 7 (2013)

Background: The aim of this study was to analyse the economic impact of nonadherence to the Global Initiative for Obstructive Lung Disease (GOLD) guidelines in patients with chronic obstructive pulmonary disease (COPD). Methods: A retrospective analy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ffdef5c2a82418897bbc64c36030d4d
https://doi.org/10.1177/1753465813484080

Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain

Autor: Eva Martinez Moragon, Fernando Sanchez-Toril Lopez, Miguel Díaz Palacios, Marta Lleonart Dormuà, Juan Jose Liñana Santafé

Publikováno v: 5.3 Allergy and Immunology.

Introduction: In a Spanish cohort of uncontrolled patients(pts) who initiated omalizumab(OMA) in the clinical practice, symptoms and exacerbations were significantly improved. Here, we describe the concomitant change in asthma-related healthcare reso

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d9088b0cb58035ec619070f3c54cbad
https://doi.org/10.1183/13993003.congress-2015.pa2562